Novo Nordisk A/S (NVO) Short Interest
WSE • NVO • DK0062498333
As of Oct 28, 2026, ORTEX estimated 0% of free float sold short, 2,327.7 days to cover, cost to borrow 1.56%. Sign up for live short interest data.
WSE • NVO • DK0062498333
As of Oct 28, 2026, ORTEX estimated 0% of free float sold short, 2,327.7 days to cover, cost to borrow 1.56%. Sign up for live short interest data.
This page tracks how heavily Novo Nordisk A/S (WSE:NVO) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Novo Nordisk A/S (WSE: NVO) has a market capitalization of $179.56B. Last close PLN 159.54 (as of 2026-11-12); 52-week range PLN 129.26 to PLN 230.00. ORTEX data as of 2026-10-28: short interest was 0.02% of free float, 2,327.7 days to cover and the average cost to borrow was 1.56%. Sign up for live short interest data.